Clinical TrialsSearch results
Number of results: 213
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Efficacy and safety of subcutaneous dupilumab for the treatment of adult participants with chronic pruritus of unknown origin (CPUO)
- Pruritus
- Tanaka Tomoyuki
- 2022-05-19
Recruiting
- Evaluation of preservation environments of preoperative acute normovolemic hemodilution
- Hemodilution
- Kataoka Erika
- 2022-04-28
Recruiting
- Exploratory study of the stool metabolic activity of Yokukansan ingredient and the pharmacokinetics of its metabolite.
- Healthy volunteers
- Hanazaki Kazuhiro
- 2021-06-08
Recruiting
- Exploratory Study on the Efficacy of "Boosted CT Myelography"
- cerebrospinal fluid hypovolemia
- Eiichi Nakai
- 2023-11-13
Recruiting
- Immunotherapy using WT1 peptide and a pertussis whole cell vaccine against recurrent prostate cancer: A phase I/II study
- Prostate cancer
- Department of Immunology, Kochi University School of Medicine
- 2009-03-31
Recruiting
- Multicenter Prospective Randomized Trial about Clinical Effect of Absorbable Suture Materials against Surgical Site Infection in Digestive Surgery
- Gastric cancer, Colorectal cancer
- Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University
- 2009-01-01
Recruiting
- Multicenter Prospective Randomized Trial about Clinical Effect of Absorbable Suture Materials against Surgical Site Infection in Hepatic Resection and Pancreatoduodenectomy
- Liver disease, Pancreas disease
- Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University
- 2009-01-01
Recruiting
- Novel Method of Assessing Urologic and Gastrointestinal Cancer Risk
- Prostate cancer, Bladder cancer, Renal cancer, Colon cancer
- Inoue Keiji
- 2022-08-30
Recruiting
- Open label, long-term study evaluating safety and efficacy of subcutaneous amlitelimab in adult participants with moderate to severe atopic dermatitis
- Dermatitis atopic
- Tanaka Tomoyuki
- 2023-03-20
Recruiting
- Phase II trial using imatinib combined with chemotherapy for newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)
- Newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)
- Japan Adult Leukemia Study Group
- 2008-07-07